Novartis accuses 2 AveXis founders of altering data, stonewalling probe — but ex-CSO blasts back
Novartis has responded to the FDA’s questions on the AveXis data manipulation scandal, blaming two “senior” execs at AveXis who had helped found the company and remained “fixtures” at the biotech for their role in stonewalling the probe and delaying their response. And the pharma giant promised that it would ramp up new plans to retrain AveXis staff and accelerate an integration plan to the global organization to make sure it never happened again.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 63,000+ biopharma pros reading Endpoints daily — and it's free.